Neutral impactResults

Rama Phosphates Q2 FY27: Date and Outlook

Univest 6 hrs ago·15 Sept 2026, 4:22 am

Rama Phosphates has announced its financial results for the second quarter of fiscal year 2027. The company reported a net profit of Rs 13.3 crore, which is a 22% increase compared to the same period last year. The company's revenue from operations grew by 15% to Rs 345 crore. The company's board has recommended a dividend of Rs 2 per share for the financial year 2026-27.

The company's performance was driven by strong demand for its products in the domestic and international markets. The company's management is confident about the future growth prospects and expects to maintain this momentum in the coming quarters. The company's management is also focused on expanding its production capacity and improving its operational efficiency.

Investors should keep an eye on the company's production volumes and the overall demand for its products in the coming quarters. The company's ability to maintain its growth momentum will be a key factor to watch. The company's dividend policy will also be a key factor to watch.

Excerpt from Univest

Rama Phosphates share price Rs 122.31 on 15 September 2026, down 0.29%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 17.00 crore. Q2 FY26 base a profit of Rs 17.00 crore. Updated: 15 Sept 2026 • 9:52 am The Rama Phosphates Q2 results date for FY27 is not confirmed, and Rama Phosphates Ltd. had not filed a…
Read the original at Univest

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Rama Phosphates (RAMAPHO).
  • Category: Results.

Why it matters

A routine update for Rama Phosphates. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Univest.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.